Public education about the relative harm of tobacco products: An intervention for tobacco control professionals

Tobacco Control

Volumn 23, Issue 5, 2014, Pages 385-388

  Biener, Lois ^a   Nyman, Amy L ^a   Stepanov, Irina ^b   Hatsukami, Dorothy ^c  

^a UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; NICOTINE; NITROSAMINE;

ADVERSE EFFECTS; ATTITUDE TO HEALTH; AWARENESS; CLINICAL TRIAL; COMPREHENSION; HUMAN; QUESTIONNAIRE; SMOKELESS TOBACCO; SMOKING CESSATION; TOBACCO; TOBACCO USE; VOCATIONAL EDUCATION;

AWARENESS; CARCINOGENS; COMPREHENSION; EDUCATION, PROFESSIONAL; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; NICOTINE; NITROSAMINES; QUESTIONNAIRES; SMOKING CESSATION; TOBACCO; TOBACCO PRODUCTS; TOBACCO USE; TOBACCO, SMOKELESS;

EID: 84906255992     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tobaccocontrol-2012-050814     Document Type: Article

References (40)

1. US Congress. The family smoking prevention and tobacco control act and federal retirement reform. Public Law No:111-31 2009;HR 1256.
2. Borland R, Yong HH, King B, et al. Use of and beliefs about light cigarettes in four countries: findings from the International Tobacco Control Policy Evaluation Survey. Nicotine Tob Res 2004;6(Suppl 3):S311-S321.
3. Kozlowski LT, Pillitteri JL. Beliefs about 'Light' and 'Ultra Light' cigarettes and efforts to change those beliefs: an overview of early efforts and published research. Tob Control 2001;10(Suppl 1):i12-i16.
4. Shiffman S, Pillitteri JL, Burton SL, et al. Smokers' beliefs about 'light' and 'ultra light' cigarettes. Tob Control 2001;10(Suppl. 1):17-23.
5. Kozlowski LT, Edwards BQ. 'Not safe' is not enough: smokers have a right to know more than there is no safe tobacco product. Tob Control 2005;14(Suppl 2):ii3-ii7.
6. Hatsukami DK, Biener L, Leischow SJ, et al. Tobacco and nicotine product testing. Nicotine Tob Res 2012;14:7-17.
7. Phillips CV, Wang C, Guenzel B. You might as well smoke; the misleading and harmful public message about smokeless tobacco. BMC Public Health 2005;5:7.
8. Waterbor JW, Adams RM, Robinson JM, et al. Disparities between public health educational materials and the scientific evidence that smokeless tobacco use causes cancer. J Cancer Educ 2004;19:17-28.
9. Gartner CE, Jimenez-Soto EV, Borland R, et al. Are Australian smokers interested in using low-nitrosamine smokeless tobacco for harm reduction? Tob Control 2010;19:6451-6456.
10. Lund KE. Association between willingness to use snus to quit smoking and perception of relative risk between snus and cigarettes. Nicotine Tob Res 2012;14:1221-1228.
11. Overland S, Hetland J, Aaro LE. Relative harm of snus and cigarettes: what do Norwegian adolescents say? Tob Control 2008;17:422-425.
12. Borland R, Cooper J, McNeill A, et al. Trends in beliefs about the harmfulness and use of stop-smoking medications and smokeless tobacco products among cigarettes smokers: findings from the ITC four-country survey. Harm Reduct J 2011;8:11.
13. Wikmans T, Ramstrom L. Harm perception among Swedish daily smokers regarding nicotine, NRT-products and Swedish Snus. Tob Induced Dis 2010;8:9.
14. O'Connor RJ, Hyland A, Giovino GA, et al. Smoker awareness of and beliefs about supposedly less-harmful tobacco products. Am J Prev Med 2005;29:85-90.
15. O'Connor RJ, McNeill A, Borland R, et al. Smokers' beliefs about the relative safety of other tobacco products: findings from the ITC collaboration. Nicotine Tob Res 2007;9:1033-1042.
16. Lund I, Scheffels J. Perceptions of the relative harmfulness of snus among norwegian general practitioners and their effect on the tendency to recommend snus in smoking cessation. Nicotine Tob Res 2012;14:169-175.
17. Peiper N, Stone R, Van Zyl R, et al. University faculty perceptions of the health risks related to cigarettes and smokeless tobacco. Drug Alcohol Rev 2010;29:121-130.
18. Heavner KK, Rosenberg Z, Tenorio F, et al. Retailers' knowledge of tobacco harm reduction following the introduction of a new brand of smokeless tobacco. Harm Reduct J 2010;7:7.
19. Biener L, Bogen K, Connolly G. Impact of corrective health information on consumers' perceptions of 'reduced exposure' tobacco products. Tob Control 2007;16:306-311.
20. Borland R, Li L, Cummings KM, et al. Effects of a Fact Sheet on beliefs about the harmfulness of alternative nicotine delivery systems compared with cigarettes. Harm Reduct J 2012;9:19.
21. O'Connor RJ, Norton K, Bansal-Travers M, et al. US smokers' reactions to a brief trial of oral nicotine products. Harm Reduct J 2011;8:1.
22. Tomar SL, Henningfield JE. Review of the evidence that pH is a determinant of nicotine dosage from oral use of smokeless tobacco. Tob Control 1997;6:219-225.
23. Stepanov I, Jensen J, Hatsukami D, et al. Tobacco-specific nitrosamines in new tobacco products. Nicotine Tob Res 2006;8:309-313.
24. Stepanov I, Jensen J, Hatsukami D, et al. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res 2008;10:1773-1782.
25. Hatsukami DK, Severson HH. Oral spit tobacco: addiction, prevention and treatment. Nicotine Tob Res 1999;1:21-44.
26. Hatsukami DK, Jensen J, Anderson A, et al. Oral tobacco products: preference and effects among smokers. Drug Alcohol Depend 2011;118:230-236.
27. Kotlyar M, Hertsgaard LA, Lindgren BR, et al. Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study. Cancer Epidemiol Biomarkers Prev 2011;20:1048.
28. Rogers JD, Biener L, Clark PI. Test marketing of new smokeless tobacco products in four US cities. Nicotine Tob Res 2010;12:69-72.
29. Hoffmann D, Djordjevic MV. Chemical composition and carcinogenicity of smokeless tobacco. AdvDent Res 1997;11:322-329.
30. International Agency for Research on Cancer. Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monographs on the evaluation of carcinogenic risks to humans Vol. 89. Lyon, France: International Agency for Research on Cancer, 2007.
31. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998;11:559-603.
32. U.S. Department of Health and Human Services. Health consequences of smoking: nicotine addiction: a report of the surgeon general. Center for Health Promotion and Education, Office on Smoking and Health, 1988.
33. U.S. Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Office on Smoking and Health, 2010.
34. Yuan JM, Gao YT, Murphy SE, et al. Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers. Cancer Res 2011;71:6749-6757.
35. 0-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers. Carcinogenesis 2011;32:1366-1371.
36. Church TR, Anderson KE, Caporaso NE, et al. A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev 2009;18:260-266.
37. Hatsukami DK, Benowitz NL, Rennard S, et al. Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob Res 2006;8: 599-622.
38. Levy DT, Mumford EA, Cummings KM, et al. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer EpidemiolBiomarkers Prev 2004;13:2035-2042.
39. Luo J, Ye W, Zendehdel K, et al. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a restrospective cohort study. Lancet 2007;369:2015-2020.
40. Stepanov I, Biener L, Knezevich A, et al. Monitoring tobacco-specific N-nitrosamines and nicotine in novel Marlboro and Camel smokeless tobacco products: findings from Round 1 of the New Product Watch. Nicotine Tob Res 2012;14:274-281.